BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

TriReme Medical Inc. Receives Shonin Approval to Market Glider™ PTCA Catheter


4/22/2013 7:04:30 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!



PLEASANTON, Calif. and SINGAPORE, April 22, 2013 /PRNewswire/ -- TriReme Medical, Inc. and its affiliates (TriReme) announced today that its Japanese partner, Century Medical, Inc. (CMI), has received Shonin approval for the Glider(TM) PTCA catheter indicated for treating the stenotic portion of coronary arteries or bypass grafts to improve myocardial perfusion. Combining a skived tip and a unique braided shaft, Glider(TM) is the world's only torqueable PTCA catheter and is designed to assist physicians in treating the most challenging cases such as bifurcations and highly stenosed lesions.

"We are proud to receive this regulatory approval for our highly differentiated Glider(TM) PTCA catheter," stated Eitan Konstantino PhD, CEO and President of TriReme. "We are looking forward to working closely with our partner, CMI. This milestone represents yet another concrete step in our strategic focus on the important Asian markets."

"Japanese cardiologists are well known for treating the most complex vascular disease," explained Akira Hoshino, President and CEO of CMI. "With its unique technology, Glider(TM) is designed to cross through tight lesions and provide improved outcomes where other balloons are challenged. Glider(TM) represents the first product, with others to follow, in our strategic partnership that will allow us to bring TriReme's cutting edge and high quality devices to Japan."

About TriReme Medical, Inc.

Based in Singapore and Pleasanton, California, TriReme Medical, Inc. is a privately held medical device company dedicated to the development, manufacturing, and commercialization of next generation percutaneous devices for the treatment of complex coronary and peripheral arterial disease. The company is focused on the US and the emerging Asian markets. TriReme has recently announced a strategic partnership with Weigao, one of China best known medical device companies.

About Century Medical

Based in Tokyo, Japan, Century Medical, Inc. is a $140 million subsidiary company of ITOCHU Corporation (TSE:ITC) a $115 billion international trading company. Century Medical, Inc., with approx. 300 employees, has a 38 year experience specializing in the importation, sale and marketing of advanced single use and implantable medical devices.

Source TriReme Medical, Inc.





Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES